# US 2012/0251607 A1 · Antimicrobial compositions, methods of preparation thereof, and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251607 A1
- Document ID: US20120251607A1
- Status: Published application
- Kind: A1
- Application number: 13/077,005
- Filed: 2011-03-31
- Published: 2012-10-04
- Earliest claimed: 2011-03-31
- Assignees: International Business Machines Corporation; Agency for Science, Technology and Research
- Inventors: Daniel J. Coady; Kazuki Fukushima; James L. Hedrick; Yi Yan Yang
- Web page: https://patentgrep.com/patent/US20120251607A1

## CPC

- A61K 31/78: of acrylic acid or derivatives thereof
- A01N 33/12: Quaternary ammonium compounds
- A61K 31/77: of oxiranes
- A61L 15/26: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof {(A61L15/225 takes precedence)}
- A61L 15/28: Polysaccharides or their derivatives {(A61L15/225 takes precedence)}
- A61L 15/46: Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
- A61L 17/10: containing macromolecular materials
- A61L 17/12: Homopolymers or copolymers of glycolic acid or lactic acid
- A61L 29/043: {Polysaccharides}
- A61L 29/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 31/10: Macromolecular materials
- A61P 31/04: Antibacterial agents
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61L 2300/40: characterised by a specific therapeutic activity or mode of action
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

A composition of matter comprises a cationic polymer comprising a polycarbonate chain fragment, the polycarbonate chain fragment comprising a repeat unit comprising a side chain moiety containing a quaternary amine group; and a non-charged polymer comprising a polyester chain segment and a poly(alkylene oxide) chain segment; wherein i) the cationic polymer and the non-charged polymer are amphiphilic and biocompatible, ii) the cationic polymer and the non-charged polymer form a mixed complex by non-covalent interactions in water, and iii) the mixed complex is a more effective antimicrobial agent against at least a Gram-negative microbe compared to the cationic polymer and the non-charged polymer alone when tested using otherwise identical conditions.

## Claims

### Claim 1

A composition of matter, comprising:
a cationic triblock copolymer having an ABA block structure, wherein a block A is a hydrophobic peripheral block, and a block B is a hydrophilic cationic core block; and
a non-charged triblock copolymer having a FEF block structure, wherein block E is a hydrophilic non-charged core block, and block F is a peripheral hydrophobic block;
wherein i) the non-charged triblock copolymer and the cationic triblock copolymer are amphiphilic and biocompatible, ii) the non-charged triblock copolymer and the cationic triblock copolymer form a mixed complex by non-covalent interactions in water, and iii) the mixed complex is a more effective antimicrobial agent against at least a Gram-negative microbe compared to the cationic triblock copolymer alone and the non-charged triblock copolymer alone when tested using otherwise identical conditions.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the block B comprises a polycarbonate chain segment comprising a repeat unit comprising a cationic side chain moiety.

### Claim 3 (depends on 2)

The composition of claim 2, wherein the cationic side chain moiety comprises a quaternary amine group.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the cationic triblock copolymer and the non-charged triblock copolymer are present in the composition in a weight ratio of about 0.25:10 w/w to about 3:2 w/w.

### Claim 5 (depends on 1)

The composition of claim 1, wherein block A, block B, block F, and optionally block E are enzymatically biodegradable,

### Claim 6 (depends on 1)

The composition of claim 1, wherein the composition comprises water and the composition is a hydrogel.

### Claim 7 (depends on 1)

The composition of claim 1, wherein block A comprises a polyester chain segment comprising a first stereospecific repeat unit, and the block F comprises a polyester chain segment comprising a second stereospecific repeat unit.

### Claim 8 (depends on 7)

The composition of claim 7, wherein the first stereospecific repeat unit is a non-superposable mirror image of the second stereospecific repeat unit.

### Claim 9 (depends on 1)

The composition of claim 1, wherein block A comprises a poly(D-lactide) chain segment and the block F comprises a poly(L-lactide) chain segment.

### Claim 10 (depends on 1)

The composition of claim 1, wherein the block A comprises a poly(L-lactide) chain segment and the block F comprises a poly(D-lactide) chain segment.

### Claim 11 (depends on 1)

The composition of claim 1, wherein the block E comprises a poly(alkylene oxide) chain segment.

### Claim 12 (depends on 11)

The composition of claim 11, wherein the poly(alkylene oxide) chain segment is a poly(ethylene oxide) chain segment.

### Claim 13 (depends on 1)

The composition of claim 1, wherein the composition is toxic to a Gram-negative microbe and to a Gram-positive microbe selected from the group consisting of bacteria, fungi, yeasts, and combinations thereof.

### Claim 14 (depends on 1)

The composition of claim 1, wherein the cationic triblock copolymer alone and the non-charged triblock copolymer alone are individually not effective antimicrobial agents against the Gram-negative microbe.

### Claim 15 (depends on 1)

The composition of claim 1, wherein the Gram-negative microbe is Escherichia coli.

### Claim 16 (depends on 1)

A loaded complex comprising i) the composition of claim 1 and ii) a drug and/or a gene.

### Claim 17 (depends on 1)

A method, comprising contacting a microbe with the composition of claim 1, thereby killing the microbe.

### Claim 18 (depends on 1)

A method, comprising:
forming an aqueous mixture of the composition of claim 1, the aqueous mixture being an effective antimicrobial agent against at least a Gram-negative microbe.

### Claim 19 (depends on 18)

The method of claim 18, wherein at a temperature of 18° C. to 28° C. and a pH of 4.5 to 8.0, the aqueous mixture is a liquid micelle solution.

### Claim 20 (depends on 18)

The method of claim 18, wherein at a temperature of 18° C. to 28° C. and a pH of 4.5 to 8.0, the aqueous mixture is a hydrogel.

### Claim 21 (depends on 18)

The method of claim 18, further comprising heating the aqueous mixture to a temperature of 32° C. to 40° C., the aqueous mixture having a pH of 4.5 to 8.0, thereby forming a hydrogel.

### Claim 22 (depends on 18)

The method of claim 18, wherein the aqueous mixture is a hydrogel, and the hydrogel comprises a rod-like structure comprising the cationic triblock copolymer and the non-charged triblock copolymer.

### Claim 23 (depends on 22)

The method of claim 22, wherein the rod-like structure has a diameter of about 100 nm to 500 nm and a length of about 0.5 micrometer to about 50 micrometers.

### Claim 24 (depends on 18)

The method of claim 18, further comprising contacting a microbe with the aqueous mixture, thereby killing the microbe.

### Claim 25 (depends on 18)

The method of claim 18, further comprising contacting an animal tissue with the aqueous mixture.

### Claim 26 (depends on 18)

The method of claim 18, further comprising contacting a surface of an article with the aqueous mixture.

### Claim 27

A method, comprising:
forming an aqueous first mixture of a cationic triblock copolymer having an ABA block structure, wherein a block A is a peripheral hydrophobic block, and a block B is a hydrophilic cationic core block;
forming an aqueous second mixture of a non-charged triblock copolymer having a FEF block structure, wherein a block E is a hydrophilic core block, and a block F is a peripheral hydrophobic block; and
combining the first mixture and the second mixture, thereby forming a third mixture comprising a mixed complex of the cationic triblock copolymer and the non-charged triblock copolymer bound by non-covalent interactions;
wherein i) the non-charged triblock copolymer and the cationic triblock copolymer are amphiphilic and biocompatible, and ii) the mixed complex is a more effective antimicrobial agent against at least a Gram-negative microbe compared to the cationic triblock copolymer alone and the non-charged triblock copolymer alone when tested under otherwise identical conditions.

### Claim 28 (depends on 27)

The method of claim 27, wherein the block A comprises a polycarbonate chain segment having a repeat unit comprising a side chain moiety, the side chain moiety comprising a quaternary amine.

### Claim 29 (depends on 27)

The method of claim 27, wherein the cationic triblock copolymer and the non-charged triblock copolymer are present in the third mixture in a weight ratio of about 0.25:10 w/w to about 3:2 w/w.

### Claim 30 (depends on 27)

The method of claim 27, wherein the cationic triblock copolymer alone and the non-charged triblock copolymer alone are individually not effective antimicrobial agents against the Gram-negative microbe when tested under otherwise identical conditions.

### Claim 31 (depends on 27)

The method of claim 27, wherein heating the third mixture to 32° C. to 40° C. produces a hydrogel.

### Claim 32 (depends on 27)

The method of claim 27, wherein removing any organic solvent at ambient temperature from the third mixture produces a hydrogel.

### Claim 33 (depends on 27)

The method of claim 27, wherein block A comprises a polyester chain segment comprising a first stereospecific repeat unit, and the block F comprises a polyester chain segment comprising a second stereospecific repeat unit.

### Claim 34 (depends on 27)

The method of claim 27, wherein the cationic triblock copolymer and/or the non-charged triblock copolymer are formed by an organocatalyzed ring opening polymerization of one or more cyclic carbonyl monomers.

### Claim 35 (depends on 27)

The method of claim 27, wherein block A, B, F, and optionally E are enzymatically biodegradable.

### Claim 36 (depends on 1)

An article comprising a medical device in contact with the composition of claim 1.

### Claim 37 (depends on 36)

The article of claim 36, wherein the medical device includes at least one of the following: a swab, a catheter, a suture, a stent, a bedpan, a glove, a facial mask, an absorbent pad, an absorbent garment, an internal absorbant device, and an insertable mechanical device.

### Claim 38

A composition of matter, comprising:
a cationic polymer comprising a polycarbonate chain fragment, the polycarbonate chain fragment comprising a repeat unit comprising a side chain moiety containing a quaternary amine group; and
a non-charged polymer comprising a polyester chain segment and a poly(alkylene oxide) chain segment;
wherein i) the cationic polymer and the non-charged polymer are amphiphilic and biocompatible, ii) the cationic polymer and the non-charged polymer form a mixed complex by non-covalent interactions in water, and iii) the mixed complex is a more effective antimicrobial agent against at least a Gram-negative microbe compared to the cationic polymer and the non-charged polymer alone when tested using otherwise identical conditions.

### Claim 39 (depends on 38)

The composition of claim 38, wherein the composition comprises water.

### Claim 40 (depends on 39)

The composition of claim 39, wherein the composition is a hydrogel.

### Claim 41 (depends on 38)

The composition of claim 38, wherein the cationic polymer comprises a first stereospecific repeat unit, and the non-charged polymer comprises a second stereospecific repeat unit.

### Claim 42 (depends on 38)

The composition of claim 38, wherein the cationic polymer is a block copolymer and the non-charged polymer is a block copolymer.

### Claim 43 (depends on 38)

The composition of claim 38, wherein the cationic polymer and the non-charged polymer alone are individually not effective antimicrobial agents against the Gram-negative microbe when tested under otherwise identical conditions.

### Claim 44 (depends on 38)

The composition of claim 38, wherein the cationic polymer is enzymatically biodegradable, and the non-charged polymer is substantially or wholly enzymatically biodegradable,

### Claim 45 (depends on 38)

The composition of claim 38, wherein the cationic polymer is a star polymer comprising three or more polymer arms.

### Claim 46 (depends on 38)

A method, comprising contacting a microbe with the composition of claim 38, thereby killing the microbe.

### Claim 47 (depends on 38)

A loaded complex comprising i) the composition of claim 38 and ii) a drug and/or a gene.

### Claim 48 (depends on 38)

A method, comprising:
forming an aqueous mixture of the composition of claim 38 wherein the aqueous mixture is an effective antimicrobial agent against at least a Gram-negative microbe.

### Claim 49

A method, comprising:
forming an aqueous first mixture containing a cationic polymer comprising a polycarbonate chain fragment, the polycarbonate chain fragment comprising a repeat unit comprising a side chain quaternary amine group;
forming an aqueous second mixture containing a non-charged polymer comprising a polyester chain segment and a poly(alkylene oxide) chain segment; and
combining the first mixture and the second mixture, thereby forming a third mixture comprising a mixed complex of the cationic polymer and the non-charged polymer bound by non-covalent interactions;
wherein i) the cationic polymer and the non-charged polymer are amphiphilic and biocompatible, and ii) the mixed complex is a more effective antimicrobial agent against at least a Gram-negative microbe compared to the cationic polymer alone and the non-charged polymer alone when tested under otherwise identical conditions.

### Claim 50 (depends on 48)

The method of claim 48, wherein the cationic polymer is a block copolymer and the non-charged polymer is a block copolymer.
